Manufacturer GW Plastics has announced it has acquired injection moulding company Avenue Mould Solutions in response to growing customer demand.

The purchase of the Ireland-based company places GW Plastics’ precision mould-building facilities in North America, Asia and Europe. GW Plastics will benefit from Avenue Mould Solutions’ expertise in building ultra-high-cavitation tooling up to 192 cavity moulds for the medical device, diagnostics, and pharmaceutical markets.

Brenan Riehl, GW Plastics President and CEO, said: “GW Plastics is thrilled to partner with the Avenue team. Avenue Mould Solutions brings to GW Plastics an experienced and highly-skilled advanced manufacturing workforce, an award-winning mould-building company, and a growing medical device contract manufacturing business that has been successfully serving Ireland and other markets for 30 years. We are pleased that Avenue has decided to join GW Plastics and help us continue to expand our capabilities to better meet our customers’ needs on a global basis.”

Felim McNeela, Avenue Mould Solution’s managing director and a founder, said: “We are delighted to partner with GW Plastics. We were drawn to the cultural fit and vision our companies share and the capital and resources GW Plastics will bring to Avenue to help us better serve our customers.” McNeela stressed that Avenue will continue to serve its existing customers and offer mould-building for customers who wish to do their own injection moulding. “GW Plastics does not wish to change Avenue’s successful history of supplying tooling to our injection moulding and contract manufacturing customers.”